Querfurth HW, LaFerla FM: Alzheimer’s disease. N Engl J Med. 2010, 362: 329-344. 10.1056/NEJMra0909142.
Article
PubMed
Google Scholar
Golde TE, Das P, Levites Y: Quantitative and mechanistic studies of Abeta immunotherapy. CNS Neurol Disord Drug Targets. 2009, 8: 31-49. 10.2174/187152709787601830.
Article
PubMed
Google Scholar
Kayed R, Jackson GR: Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders. Curr Opin Immunol. 2009, 21: 359-363. 10.1016/j.coi.2009.05.001.
Article
PubMed
Google Scholar
Robinson SR, Bishop GM, Lee HG, Münch G: Lessons from the AN 1792 Alzheimer vaccine: lest we forget. Neurobiol Aging. 2004, 25: 609-615. 10.1016/j.neurobiolaging.2003.12.020.
Article
PubMed
Google Scholar
Grundman M, Dibernardo A, Raghavan N, Krams M, Yuen E: 2012: a watershed year for Alzheimer’s disease research. J Nutr Health Aging. 2013, 17: 51-53. 10.1007/s12603-013-0002-2.
Article
PubMed
Google Scholar
Liu YH, Giunta B, Zhou HD, Tan J, Wang YJ: Immunotherapy for Alzheimer disease: the challenge of adverse effects. Nat Rev Neurol. 2012, 8: 465-469.
PubMed
Google Scholar
Gelfand EW: Intravenous immune globulin in autoimmune and inflammatory diseases. N Engl J Med. 2015–2025, 2012: 367.
Google Scholar
Dodel R, Neff F, Noelker C, Pul R, Du Y, Bacher M, Oertel W: Intravenous immunoglobulins as a treatment for Alzheimer’s disease: rationale and current evidence. Drugs. 2010, 70: 513-528. 10.2165/11533070-000000000-00000.
Article
PubMed
Google Scholar
Szabo P, Relkin N, Weksler ME: Natural human antibodies to amyloid beta peptide. Autoimmun Rev. 2008, 7: 415-420. 10.1016/j.autrev.2008.03.007.
Article
PubMed
Google Scholar
Dodel RC, Du Y, Depboylu C, Hampel H, Frolich L, Haag A, Hemmeter U, Paulsen S, Teipel SJ, Brettschneider S, Spottke A, Nolker C, Moller HJ, Wei X, Farlow M, Sommer N, Oertel WH: Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2004, 75: 1472-1474. 10.1136/jnnp.2003.033399.
Article
PubMed Central
PubMed
Google Scholar
Relkin NR, Szabo P, Adamiak B, Burgut T, Monthe C, Lent RW, Younkin S, Younkin L, Schiff R, Weksler ME: 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease. Neurobiol Aging. 2008, 30: 1728-1736.
Article
PubMed
Google Scholar
Relkin N: Results of the GAP 160701 study: a phase 3 clinical trial of intravenous immunoglobulin for mild to moderate Alzheimer’s disease - Norman Relkin on behalf of the ADCS and Baxter Gap 160701 study group. AAIC. 2013, 9 (4): 39689.
Google Scholar
Liu CC, Kanekiyo T, Xu H, Bu G: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 1991, 9: 106-118.
Article
Google Scholar
Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Forster S, Winter Y, Bach JP, Popp J, Alferink J, Wiltfang J, Buerger K, Otto M, Antuono P, Jacoby M, Richter R, Stevens J, Melamed I, Goldstein J, Haag S, Wietek S, Farlow M, Jessen F: Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer’s disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurol. 2013, 12: 233-243. 10.1016/S1474-4422(13)70014-0.
Article
PubMed
Google Scholar
Fillit H, Hess G, Hill J, Bonnet P, Toso C: IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders. Neurology. 2009, 73: 180-185. 10.1212/WNL.0b013e3181ae7aaf.
Article
PubMed
Google Scholar
Mayeux R, Stern Y: Epidemiology of Alzheimer disease. Cold Spring Harbor Perspect Med. 2012, 2: a006239-doi:10.1101/cshperspect.a006239
Article
Google Scholar
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003, 39: 409-421. 10.1016/S0896-6273(03)00434-3.
Article
PubMed
Google Scholar
Arsenault D, Julien C, Tremblay C, Calon F: DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS One. 2011, 6: e17397-10.1371/journal.pone.0017397.
Article
PubMed Central
PubMed
Google Scholar
Bories C, Guitton MJ, Julien C, Tremblay C, Vandal M, Msaid M, de Koninck Y, Calon F: Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer’s disease. PLoS One. 2012, 7: e46111-10.1371/journal.pone.0046111.
Article
PubMed Central
PubMed
Google Scholar
Latapy C, Rioux V, Guitton MJ, Beaulieu JM: Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotonin-sensitive anxiety and social behaviour. Philos Trans R Soc Lond B Biol Sci. 2012, 367: 2460-2474. 10.1098/rstb.2012.0094.
Article
PubMed Central
PubMed
Google Scholar
Drouin-Ouellet J, LeBel M, Filali M, Cicchetti F: MyD88 deficiency results in both cognitive and motor impairments in mice. Brain Behav Immun. 2012, 26: 880-885. 10.1016/j.bbi.2012.02.007.
Article
PubMed
Google Scholar
Lebbadi M, Julien C, Phivilay A, Tremblay C, Emond V, Kang JX, Calon F: Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer’s disease. J Alzheimers Dis. 2011, 27: 853-869.
PubMed
Google Scholar
Kim J, Castellano JM, Jiang H, Basak JM, Parsadanian M, Pham V, Mason SM, Paul SM, Holtzman DM: Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance. Neuron. 2009, 64: 632-644. 10.1016/j.neuron.2009.11.013.
Article
PubMed Central
PubMed
Google Scholar
St-Amour I, Bousquet M, Pare I, Drouin-Ouellet J, Cicchetti F, Bazin R, Calon F: Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson’s disease. J Neuroinflammation. 2012, 9: 234-10.1186/1742-2094-9-234.
Article
PubMed Central
PubMed
Google Scholar
Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puolivali J, Lesne S, Ashe KH, Muchowski PJ, Mucke L: Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem. 2007, 282: 23818-23828. 10.1074/jbc.M701078200.
Article
PubMed
Google Scholar
Czirr E, Wyss-Coray T: The immunology of neurodegeneration. J Clin Invest. 2012, 122: 1156-1163. 10.1172/JCI58656.
Article
PubMed Central
PubMed
Google Scholar
Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K: Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med. 2013, 368: 107-116. 10.1056/NEJMoa1211103.
Article
PubMed Central
PubMed
Google Scholar
Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J: TREM2 variants in Alzheimer’s disease. N Engl J Med. 2013, 368: 117-127. 10.1056/NEJMoa1211851.
Article
PubMed Central
PubMed
Google Scholar
Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fievet N, Barberger-Gateau P, Engelborghs S, de Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009, 41: 1094-1099. 10.1038/ng.439.
Article
PubMed
Google Scholar
Gimenez-Llort L, Mate I, Manassra R, Vida C, de la Fuente M: Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer’s disease. Ann N Y Acad Sci. 2012, 1262: 74-84. 10.1111/j.1749-6632.2012.06639.x.
Article
PubMed
Google Scholar
Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM: Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease. J Neurosci. 2005, 25: 8843-8853. 10.1523/JNEUROSCI.2868-05.2005.
Article
PubMed
Google Scholar
Mastrangelo MA, Bowers WJ: Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer’s disease-related pathologies in male triple-transgenic mice. BMC Neurosci. 2008, 9: 81-10.1186/1471-2202-9-81.
Article
PubMed Central
PubMed
Google Scholar
Bonneh-Barkay D, Wang G, Starkey A, Hamilton RL, Wiley CA: In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases. J Neuroinflammation. 2010, 7: 34-10.1186/1742-2094-7-34.
Article
PubMed Central
PubMed
Google Scholar
Prinz M, Priller J: Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol. 2010, 224: 80-84. 10.1016/j.jneuroim.2010.05.015.
Article
PubMed
Google Scholar
Liu Z, Condello C, Schain A, Harb R, Grutzendler J: CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J Neurosci. 2010, 30: 17091-17101. 10.1523/JNEUROSCI.4403-10.2010.
Article
PubMed Central
PubMed
Google Scholar
Lee S, Varvel NH, Konerth ME, Xu G, Cardona AE, Ransohoff RM, Lamb BT: CX3CR1 Deficiency alters microglial activation and reduces beta-amyloid deposition in Two Alzheimer’s disease mouse models. Am J Pathol. 2010, 177: 2549-2562. 10.2353/ajpath.2010.100265.
Article
PubMed Central
PubMed
Google Scholar
Fuhrmann M, Bittner T, Jung CKE, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J: Microglial CX3CR1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat Neurosci. 2010, 13: 411-413. 10.1038/nn.2511.
Article
PubMed Central
PubMed
Google Scholar
Puli L, Pomeshchik Y, Olas K, Malm T, Koistinaho J, Tanila H: Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease. J Neuroinflammation. 2012, 9: 105-10.1186/1742-2094-9-105.
Article
PubMed Central
PubMed
Google Scholar
Schellenberg GD, Montine TJ: The genetics and neuropathology of Alzheimer’s disease. Acta Neuropathol. 2012, 124: 305-323. 10.1007/s00401-012-0996-2.
Article
PubMed Central
PubMed
Google Scholar
Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, Corsmit E, Cruts M, Dermaut B, Wang R, Van Broeckhoven C: Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat. 2006, 27: 686-695. 10.1002/humu.20336.
Article
PubMed
Google Scholar
Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE: Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A. 2006, 103: 5161-5166. 10.1073/pnas.0600948103.
Article
PubMed Central
PubMed
Google Scholar
Mookherjee P, Green PS, Watson GS, Marques MA, Tanaka K, Meeker KD, Meabon JS, Li N, Zhu P, Olson VG, Cook DG: GLT-1 loss accelerates cognitive deficit onset in an Alzheimer’s disease animal model. J Alzheimers Dis. 2011, 26: 447-455.
PubMed Central
PubMed
Google Scholar
Sokolow S, Henkins KM, Bilousova T, Miller CA, Vinters HV, Poon W, Cole GM, Gylys KH: AD synapses contain abundant Abeta monomer and multiple soluble oligomers, including a 56-kDa assembly. Neurobiol Aging. 2012, 33: 1545-1555. 10.1016/j.neurobiolaging.2011.05.011.
Article
PubMed Central
PubMed
Google Scholar
Handoko M, Grant M, Kuskowski M, Zahs KR, Wallin A, Blennow K, Ashe KH: Correlation of specific amyloid-beta oligomers with Tau in cerebrospinal fluid from cognitively normal older adults. JAMA Neurol. 2013, 70: 594-599. 10.1001/jamaneurol.2013.48.
Article
PubMed Central
PubMed
Google Scholar
Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH: A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006, 440: 352-357. 10.1038/nature04533.
Article
PubMed
Google Scholar
Reed MN, Hofmeister JJ, Jungbauer L, Welzel AT, Yu C, Sherman MA, Lesne S, LaDu MJ, Walsh DM, Ashe KH, Cleary JP: Cognitive effects of cell-derived and synthetically derived Abeta oligomers. Neurobiol Aging. 2011, 32: 1784-1794. 10.1016/j.neurobiolaging.2009.11.007.
Article
PubMed Central
PubMed
Google Scholar
Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH: Brain amyloid-beta oligomers in ageing and Alzheimer’s disease. Brain. 2013, 136: 1383-1398. 10.1093/brain/awt062.
Article
PubMed Central
PubMed
Google Scholar
Gong B, Pan Y, Zhao W, Knable L, Vempati P, Begum S, Ho L, Wang J, Yemul S, Barnum S, Bilski A, Gong BY, Pasinetti GM: IVIG immunotherapy protects against synaptic dysfunction in Alzheimer’s disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway. Mol Immunol. 2013, 56: 619-629. 10.1016/j.molimm.2013.06.016.
Article
PubMed
Google Scholar
Aukrust P, Muller F, Nordoy I, Haug CJ, Froland SS: Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo. Clin and Exp Immunol. 1997, 107: 50-56. 10.1046/j.1365-2249.1997.d01-904.x.
Article
Google Scholar
Stuve O, Marra CM, Bar-Or A, Niino M, Cravens PD, Cepok S, Frohman EM, Phillips JT, Arendt G, Jerome KR, Cook L, Grand’Maison F, Hemmer B, Monson NL, Racke MK: Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol. 2006, 63: 1383-1387. 10.1001/archneur.63.10.1383.
Article
PubMed
Google Scholar
Marousi S, Karkanis I, Kalamatas T, Travasarou M, Paterakis G, Karageorgiou CE: Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety. Acta Neurol Scand. 2013, 128: e1-e5. 10.1111/ane.12080.
Article
PubMed
Google Scholar
Schindowski K, Peters J, Gorriz C, Schramm U, Weinandi T, Leutner S, Maurer K, Frolich L, Muller WE, Eckert A: Apoptosis of CD4+ T and natural killer cells in Alzheimer’s disease. Pharmacopsychiatry. 2006, 39: 220-228. 10.1055/s-2006-954591.
Article
PubMed
Google Scholar
Pirttila T, Mattinen S, Frey H: The decrease of CD8-positive lymphocytes in Alzheimer’s disease. J Neurol Sci. 1992, 107: 160-165. 10.1016/0022-510X(92)90284-R.
Article
PubMed
Google Scholar
Ikeda T, Yamamoto K, Takahashi K, Yamada M: Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with Alzheimer’s disease. Acta Psychiatr Scand. 1991, 83: 444-448. 10.1111/j.1600-0447.1991.tb05573.x.
Article
PubMed
Google Scholar
Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, Fulop T: Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer’s disease. J Alzheimers Dis. 2009, 17: 91-103.
PubMed
Google Scholar
Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D’Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM: YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer’s disease. Biol Psychiatry. 2010, 68: 903-912. 10.1016/j.biopsych.2010.08.025.
Article
PubMed Central
PubMed
Google Scholar
Azizi G, Mirshafiey A: The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis. Immunopharmacol Immunotoxicol. 2012, 34: 881-895. 10.3109/08923973.2012.705292.
Article
PubMed
Google Scholar
Eriksson UK, Gatz M, Dickman PW, Fratiglioni L, Pedersen NL: Asthma, eczema, rhinitis and the risk for dementia. Dement Geriatr Cogn Disord. 2008, 25: 148-156. 10.1159/000112729.
Article
PubMed
Google Scholar
Kenyon NJ, Kelly EA, Jarjour NN: Enhanced cytokine generation by peripheral blood mononuclear cells in allergic and asthma subjects. Ann Allergy Asthma Immunol. 2000, 85: 115-120. 10.1016/S1081-1206(10)62450-7.
Article
PubMed
Google Scholar
Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV: Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 2008, 320: 373-376. 10.1126/science.1154315.
Article
PubMed Central
PubMed
Google Scholar
Anthony RM, Kobayashi T, Wermeling F, Ravetch JV: Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 2011, 475: 110-113. 10.1038/nature10134.
Article
PubMed Central
PubMed
Google Scholar
Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV: General mechanism for modulating immunoglobulin effector function. Proc Natl Acad Sci U S A. 2013, 110: 9868-9872. 10.1073/pnas.1307864110.
Article
PubMed Central
PubMed
Google Scholar
Park JY, Choi HJ, Prabagar MG, Choi WS, Kim SJ, Cheong C, Park CG, Chin CY, Kang YS: The C–type lectin CD209b is expressed on microglia and it mediates the uptake of capsular polysaccharides of Streptococcus pneumoniae. Neurosci Lett. 2009, 450: 246-251. 10.1016/j.neulet.2008.11.070.
Article
PubMed
Google Scholar
Olsson B, Ridell B, Carlsson L, Jacobsson S, Wadenvik H: Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. Blood. 2008, 112: 1078-1084. 10.1182/blood-2008-02-139402.
Article
PubMed
Google Scholar
Bhaskar K, Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT: Regulation of tau pathology by the microglial fractalkine receptor. Neuron. 2010, 68: 19-31. 10.1016/j.neuron.2010.08.023.
Article
PubMed Central
PubMed
Google Scholar
Cho S-H, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L: CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem. 2011, 286: 32713-32722. 10.1074/jbc.M111.254268.
Article
PubMed Central
PubMed
Google Scholar
Desforges NM, Hebron ML, Algarzae NK, Lonskaya I, Moussa CE: Fractalkine mediates communication between pathogenic proteins and microglia: implications of anti-inflammatory treatments in different stages of neurodegenerative diseases. Int J Alzheimers Dis. 2012, 2012: 345472.
PubMed Central
PubMed
Google Scholar
Smolders J, Remmerswaal EB, Schuurman KG, Melief J, van Eden CG, van Lier RA, Huitinga I, Hamann J: Characteristics of differentiated CD8(+) and CD4 (+) T cells present in the human brain. Acta Neuropathol. 2013, 126: 525-535. 10.1007/s00401-013-1155-0.
Article
PubMed
Google Scholar